Plan helps accounts choose the right solutions to keep employees healthy and lower health care costs
BOSTON, April 2, 2018 /PRNewswire-USNewswire/ -- Digital health is a hotbed for innovation, with venture capitalists spending nearly $5 billion in the space last year (think FitBits, Smart Scales, and wellness apps). With the constant surge in new products and services entering the market, it's often difficult for companies to know which solutions can best address their employees' unique health challenges. That's why Blue Cross Blue Shield of Massachusetts (Blue Cross) is introducing the Emerging Solutions platform to curate market-leading health solutions and provide advice to employer customers on which solutions could best help improve their employees' health.
Emerging Solutions is available to self-insured accounts with 1,000+ employees starting July 1, 2018. Currently, our offering includes nationally recognized solutions for diabetes prevention and management as well as fertility, pregnancy, and parenting—key health issues that are of interest to our accounts. These solutions are:
Livongo, the leading consumer digital health platform that empowers people with chronic conditions like diabetes to live better and healthier lives.
Omada, a digital provider of the Diabetes Prevention Program, delivering the tools and support for participants to improve lifestyle, behavior, and overall health.
Ovia Health, which uses technology and predictive coaching to support women from preconception and pregnancy through return-to-work and parenthood.
Read More: https://www.prnewswire.com/news-releases/blue-cross-blue-shield-of-massachusetts-launches-portfolio-of-digital-health-solutions-300622601.html
Via: Cision PR Newswire
Via: FOX17 News
GRAND RAPIDS, Mich. -- There's a new life-saving procedure that's helping patients at Spectrum Health in Grand Rapids.
SUNNYVALE, Calif.--(BUSINESS WIRE)--Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced that medical device industry veteran Donald J. Zurbay has joined its board of directors.
OncoMed Announces Appointment of John Lewicki, PhD, as President, Chief Executive Officer and a member of the Board of Directors
REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced the appointment of Dr. John Lewicki as President and Chief Executive Officer of OncoMed, effective immediately. Dr. Lewicki was also appointed to the company's Board of Directors.
Via: Trinity Ventures
People who are diagnosed with prediabetes can delay or prevent the disease if they change their lifestyle and lose a significant amount of weight. But here's the challenge: How can people be motivated to eat healthier and move more? Increasingly, the answer might include digital medicine.
Intimidating medical devices can cause anxiety for patients — in the same way that people can experience “white coat hypertension” when seeing a doctor.
HOLLYWOOD, Fla. — Several new technologies are available or on the horizon to improve the outcomes of carotid artery stenting, according to a speaker at the International Symposium on Endovascular Therapy (ISET).
Via: Wall Street Journal
The ‘thrombectomy’ is transforming stroke care, pre-empting brain damage in many patients, but the medical establishment is far from making it standard practice